502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797630653372563456 |
|---|---|
| author | Faming Zhang Dawei Chen Henry Li Hang Ke Cen Chen Jialing Li Feiyu Peng |
| author_facet | Faming Zhang Dawei Chen Henry Li Hang Ke Cen Chen Jialing Li Feiyu Peng |
| author_sort | Faming Zhang |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:11:13Z |
| format | Article |
| id | doaj.art-18b6f437969b4e09b4aa56c988659547 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:11:13Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-18b6f437969b4e09b4aa56c9886595472023-11-12T02:50:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0502502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapyFaming Zhang0Dawei Chen1Henry Li2Hang Ke3Cen Chen4Jialing Li5Feiyu Peng6Department of Microbiota Medicine and Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, ChinaDepartment of Radiation Oncology and Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China2Hanx Biopharmaceuticals, Inc., Oceanside, CA, USA2Hanx Pharmaceuticals, Inc., Wuhan, ChinaDepartment of Anesthesiology, First Affiliated Hospital of Anhui Medical University, Hefei, China1Hanx Biopharmaceuticals, Inc., Wuhan, HuBei, China1Hanx Biopharmaceuticals, Inc., Wuhan, HuBei, China |
| spellingShingle | Faming Zhang Dawei Chen Henry Li Hang Ke Cen Chen Jialing Li Feiyu Peng 502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy Journal for ImmunoTherapy of Cancer |
| title | 502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy |
| title_full | 502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy |
| title_fullStr | 502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy |
| title_full_unstemmed | 502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy |
| title_short | 502 Discovery of HX017, a novel NKG2A/CD94 mAb, for potential cancer immunotherapy |
| title_sort | 502 discovery of hx017 a novel nkg2a cd94 mab for potential cancer immunotherapy |
| work_keys_str_mv | AT famingzhang 502discoveryofhx017anovelnkg2acd94mabforpotentialcancerimmunotherapy AT daweichen 502discoveryofhx017anovelnkg2acd94mabforpotentialcancerimmunotherapy AT henryli 502discoveryofhx017anovelnkg2acd94mabforpotentialcancerimmunotherapy AT hangke 502discoveryofhx017anovelnkg2acd94mabforpotentialcancerimmunotherapy AT cenchen 502discoveryofhx017anovelnkg2acd94mabforpotentialcancerimmunotherapy AT jialingli 502discoveryofhx017anovelnkg2acd94mabforpotentialcancerimmunotherapy AT feiyupeng 502discoveryofhx017anovelnkg2acd94mabforpotentialcancerimmunotherapy |